Neuberger Berman Group »

Akebia Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $38k 33k 1.14

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Microsoft Corp Common (MSFT)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Broadcom Common (AVGO)
Asml Holding Adr Representing Nv Common (ASML)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Nextera Energy Common (NEE)
Analog Devices Common (ADI)

View all positions for Neuberger Berman Group

Top funds holding Akebia Therapeutics

BlackRock
State Street Corporation
Vanguard Capital Management
AQR Capital Management
Geode Capital Management
Jacobs Levy Equity Management
Acadian Asset Management
Goldman Sachs Group
Millennium Management
Citigroup
Vanguard Portfolio Management
Two Sigma Investments
Charles Schwab Investment Management
Sixth Street Partners Management Company
Northern Trust

View all funds holding Akebia Therapeutics